MYTH: SGLT2 inhibitors are used only to improve blood glucose levels. FACT: SGL…

MYTH: SGLT2 inhibitors are used only to improve blood glucose levels.

FACT: SGLT2 inhibitors with demonstrated clinical benefit can also reduce chronic kidney disease progression and cardiovascular events in eligible patients with type 2 diabetes and CKD. Their kidney-protective effects extend beyond glucose lowering.

Clinical pearl: Consider kidney function, albuminuria, cardiovascular risk and treatment eligibility when individualising therapy.

Reference: https://diabetesjournals.org/care/article/49/Supplement_1/S246/163914/11-Chronic-Kidney-Disease-and-Risk-Management

#DiabetesCare #CKD #CardiorenalHealth #SGLT2Inhibitors